Sodium phosphate, monobasic

Identification

Summary

Sodium phosphate, monobasic is a source of phosphorus used prevent or correct hypophosphatemia in patients with restricted or no oral intake.

Brand Names
As 3, Cpda-1 Blood Collection System, Glycerolyte 57, Intersol, Ionosol-MB, K-phos Neutral, K-phos No 2, Leukotrap, Osmoprep, Phosphasal, Rejuvesol, Urelle, Uribel, Urimar Reformulated Oct 2013, Urin DS, Ustell
Generic Name
Sodium phosphate, monobasic
DrugBank Accession Number
DB09449
Background

Sodium phosphate is a saline laxative that is thought to work by increasing fluid in the small intestine. It usually results in a bowel movement after 30 minutes to 6 hours.

Type
Small Molecule
Groups
Approved
Structure
Weight
Average: 119.977
Monoisotopic: 119.958839739
Chemical Formula
H2NaO4P
Synonyms
  • Disodium hydrogen phosphate anhydrous
  • Monosodium dihydrogen monophosphate
  • Monosodium dihydrogen orthophosphate
  • Monosodium monophosphate
  • Monosodium phosphate, anhydrous
  • Phosphoric acid, monosodium salt, anhydrous
  • Sodium acid phosphate
  • Sodium biphosphate, anhydrous
  • Sodium dihydrogen phosphate
  • Sodium dihydrogen phosphate, anhydrous
  • Sodium orthophosphate
  • Sodium orthophosphate monobasic
  • Sodium phosphate monobasic
  • Sodium phosphate monobasic (anhydrate)
  • Sodium phosphate monobasic (anhydrous)
  • Sodium phosphate, monobasic
  • Sodium phosphate, monobasic anhydrous
  • Sodium phosphate,monobasic
  • Sodium primary phosphate
External IDs
  • E-339(I)
  • INS NO.339(I)
  • INS-339(I)

Pharmacology

Indication

Used to treat constipation or to clean the bowel before a colonoscopy Label.

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to treatAcid-base imbalanceCombination Product in combination with: Potassium chloride (DB00761), Sodium bicarbonate (DB01390), Sodium phosphate, dibasic (DB14502), Magnesium chloride (DB09407), Calcium chloride (DB01164), Sodium chloride (DB09153)••••••••••••
Used in combination to treatAcidosisCombination Product in combination with: Monopotassium phosphate (DB09413), Magnesium chloride (DB09407), Dextrose, unspecified form (DB09341), Potassium chloride (DB00761), Lactic acid (DB04398)••••••••••••••••••
Used in combination to treatBurnsCombination Product in combination with: Lactic acid (DB04398), Potassium chloride (DB00761), Magnesium chloride (DB09407), Monopotassium phosphate (DB09413), Dextrose, unspecified form (DB09341)••••••••••••••••••
Used in combination to treatConstipationCombination Product in combination with: Sodium phosphate, dibasic (DB14502)•••••••••••••••••
Used in combination to treatDehydrationCombination Product in combination with: Sodium chloride (DB09153), Lactic acid (DB04398), Dextrose, unspecified form (DB09341), Potassium chloride (DB00761), Magnesium chloride (DB09407)••••••••••••••••••••
Associated Therapies
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Sodium phosphate inceases fecal water content to increase mobility through the large intestine 1.

Mechanism of action

Sodium phosphate is thought to work by increasing the amount of solute present in the intestinal lumen thereby creating an osmotic gradient which draws water into the lumen 1.

Absorption

Tmax for phosphate absorption with orally administered liquid sodium phosphate is 1-3h 3.

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Intamuscular LD50 of 250mg/kg and oral LD50 of 8290 mg/kg reported in rats 7. Phosphate toxicity is likely due to the disturbance of other electrolytes when phosphate levels are high, producing symptoms including tetany, dehydration, hypotension, tachycardia, hyperpyrexia, cardiac arrest and coma 4. Risk of raising phosphate levels through use of sodium phosphate appears to be higher in smaller patients 3.

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcebutololSodium phosphate, monobasic may increase the hyperkalemic activities of Acebutolol.
AceclofenacThe risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Aceclofenac.
AcemetacinThe risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Acemetacin.
AcetazolamideAcetazolamide may increase the nephrotoxic activities of Sodium phosphate, monobasic.
Acetylsalicylic acidThe risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Acetylsalicylic acid.
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Sodium phosphate, monobasic, dihydrate5QWK66595613472-35-0VBJGJHBYWREJQD-UHFFFAOYSA-M
Sodium phosphate, monobasic, monohydrate593YOG76RN10049-21-5BBMHARZCALWXSL-UHFFFAOYSA-M
Active Moieties
NameKindUNIICASInChI Key
Sodium cationionicLYR4M0NH3717341-25-2FKNQFGJONOIPTF-UHFFFAOYSA-N
Phosphate ionionicNK08V8K8HR14265-44-2NBIIXXVUZAFLBC-UHFFFAOYSA-K
Phosphoric acidunknownE4GA8884NN7664-38-2NBIIXXVUZAFLBC-UHFFFAOYSA-N
Product Images
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Additive Formula 3Sodium phosphate, monobasic, monohydrate (0.28 g/100mL) + Adenine (0.03 g/100mL) + Citric acid monohydrate (0.042 g/100mL) + D-glucose monohydrate (1.1 g/100mL) + Sodium chloride (0.41 g/100mL) + Sodium citrate dihydrate (0.59 g/100mL)SolutionIntravenousTerumo Bct, Ltd2002-05-29Not applicableUS flag
Additive Formula 3Sodium phosphate, monobasic, monohydrate (0.28 g/100mL) + Adenine (0.03 g/100mL) + Citric acid monohydrate (0.042 g/100mL) + D-glucose monohydrate (1.1 g/100mL) + Sodium chloride (0.41 g/100mL) + Sodium citrate dihydrate (0.59 g/100mL)SolutionIntravenousTerumo Bct, Ltd2002-05-29Not applicableUS flag
Additive Formula 3Sodium phosphate, monobasic, monohydrate (0.28 g/100mL) + Adenine (0.03 g/100mL) + Citric acid monohydrate (0.042 g/100mL) + D-glucose monohydrate (1.1 g/100mL) + Sodium chloride (0.41 g/100mL) + Sodium citrate dihydrate (0.59 g/100mL)SolutionIntravenousTerumo Bct, Ltd2002-05-29Not applicableUS flag
Additive Formula 3Sodium phosphate, monobasic, monohydrate (0.28 g/100mL) + Adenine (0.03 g/100mL) + Citric acid monohydrate (0.042 g/100mL) + D-glucose monohydrate (1.1 g/100mL) + Sodium chloride (0.41 g/100mL) + Sodium citrate dihydrate (0.59 g/100mL)SolutionIntravenousTerumo Bct, Ltd2002-05-29Not applicableUS flag
Additive Formula 3Sodium phosphate, monobasic, monohydrate (0.28 g/100mL) + Adenine (0.03 g/100mL) + Citric acid monohydrate (0.042 g/100mL) + D-glucose monohydrate (1.1 g/100mL) + Sodium chloride (0.41 g/100mL) + Sodium citrate dihydrate (0.59 g/100mL)SolutionIntravenousTerumo Bct, Ltd2002-05-29Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Azuphen MbSodium phosphate, monobasic, monohydrate (40.8 mg/1) + Hyoscyamine sulfate dihydrate (0.12 mg/1) + Methenamine (120 mg/1) + Methylene blue trihydrate (10 mg/1) + Phenyl salicylate (36 mg/1)CapsuleOralBurel Pharmaceuticals, Llc2015-09-282016-11-01US flag
B.T.ENEMA 135 ML SOLUSYONSodium phosphate, monobasic (135 ml)SolutionRectalYENİŞEHİR LABORATUARI LTD. ŞTİ.2013-01-292022-04-11Turkey flag
B.T.ENEMA 210 ML LAVMANSodium phosphate, monobasic (9.5 g/59ml) + Sodium phosphate, dibasic (3.5 g/59ml)EnemaRectalYENİŞEHİR LABORATUARI LTD. ŞTİ.2013-01-292022-04-11Turkey flag
B.T.ENEMA 67,5 ML LAVMANSodium phosphate, monobasic (9.5 g/59ml) + Sodium phosphate, dibasic (3.5 g/59ml)EnemaRectalYENİŞEHİR LABORATUARI LTD. ŞTİ.2013-01-292022-04-11Turkey flag
BT ORAL SOLUSYON 45 MLSodium phosphate, monobasic (45 ml)SolutionOralYENİŞEHİR LABORATUARI LTD. ŞTİ.2020-08-14Not applicableTurkey flag

Categories

ATC Codes
A06AG01 — Sodium phosphateV03AG05 — Sodium phosphateA06AD17 — Sodium phosphateB05XA09 — Sodium phosphate
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of inorganic compounds known as alkali metal phosphates. These are inorganic compounds in which the largest oxoanion is phosphate, and in which the heaviest atom not in an oxoanion is an alkali metal.
Kingdom
Inorganic compounds
Super Class
Mixed metal/non-metal compounds
Class
Alkali metal oxoanionic compounds
Sub Class
Alkali metal phosphates
Direct Parent
Alkali metal phosphates
Alternative Parents
Inorganic sodium salts / Inorganic oxides
Substituents
Alkali metal phosphate / Inorganic oxide / Inorganic salt / Inorganic sodium salt
Molecular Framework
Not Available
External Descriptors
sodium phosphate (CHEBI:37585)
Affected organisms
Not Available

Chemical Identifiers

UNII
KH7I04HPUU
CAS number
7558-80-7
InChI Key
AJPJDKMHJJGVTQ-UHFFFAOYSA-M
InChI
InChI=1S/Na.H3O4P/c;1-5(2,3)4/h;(H3,1,2,3,4)/q+1;/p-1
IUPAC Name
sodium dihydrogen phosphate
SMILES
[Na+].OP(O)([O-])=O

References

General References
  1. Rex DK: Dosing considerations in the use of sodium phosphate bowel preparations for colonoscopy. Ann Pharmacother. 2007 Sep;41(9):1466-75. Epub 2007 Jul 24. [Article]
  2. Schanz S, Kruis W, Mickisch O, Kuppers B, Berg P, Frick B, Heiland G, Huppe D, Schenck B, Horstkotte H, Winkler A: Bowel Preparation for Colonoscopy with Sodium Phosphate Solution versus Polyethylene Glycol-Based Lavage: A Multicenter Trial. Diagn Ther Endosc. 2008;2008:713521. doi: 10.1155/2008/713521. [Article]
  3. Ehrenpreis ED: Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis. Aliment Pharmacol Ther. 2009 Jun 1;29(11):1202-11. doi: 10.1111/j.1365-2036.2009.03987.x. Epub 2009 Feb 27. [Article]
  4. Razzaque MS: Phosphate toxicity: new insights into an old problem. Clin Sci (Lond). 2011 Feb;120(3):91-7. doi: 10.1042/CS20100377. [Article]
  5. Biber J, Hernando N, Forster I: Phosphate transporters and their function. Annu Rev Physiol. 2013;75:535-50. doi: 10.1146/annurev-physiol-030212-183748. [Article]
  6. FDA Guide: Sodium Phosphate Tablet [Link]
  7. ChemIDPlus: Sodium Phosphate [Link]
PubChem Compound
23672064
PubChem Substance
347827853
ChemSpider
22626
ChEBI
37585
ChEMBL
CHEMBL1368
Wikipedia
Sodium_phosphates
FDA label
Download (359 KB)
MSDS
Download (84.7 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedNot AvailableDry Eyes1
4CompletedDiagnosticColonoscopy1
4CompletedDiagnosticPolyethylene Glycols / Sodium Phosphate1
4CompletedOtherSickle Cell Disease (SCD)1
4CompletedTreatmentCathartic Colon1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Kit; solutionIntravenous
InjectionIntravenous0.5 g/l
InjectionIntravenous0.25 g/1000ml
SolutionRectal135 ml
SolutionOral45 ml
SolutionOral90 ml
SolutionOral
Solution, concentrateRectal
LiquidIntravenous
KitIntravenous
PasteDental
InjectionIntrathecal
SolutionParenteral
SolutionRectal
LiquidIrrigation
SolutionRectal133 ml
SolutionRectal66.6 ml
SolutionRectal90 ml
SuppositoryParenteral
SolutionUnknown
LiquidIntravesical
Injection, solutionIntravenous
Tablet, coatedOral
SolutionIntravenous0.775 g
EmulsionParenteral
EmulsionIntravenous
Injection, emulsionIntravenous4.656 g/1000ml
Injection, emulsionIntravenous6.792 g/1000ml
Injection, emulsionIntravenous
TabletOral
CapsuleOral
LiquidOral
SolutionOral1.2 g/5ml
SolutionExtracorporeal
SolutionRectal16 %/6%
SolutionRectal
EnemaRectal
SolutionRespiratory (inhalation)
Injection, solution, concentrateIntravenous
SolutionIntravenous
SolutionOral0.9 g/5ml
Tablet, film coatedOral
Tablet, sugar coatedOral
Syrup
Enema
Solution
Prices
Not Available
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)Region
US7687075No2010-03-302028-06-22US flag
US7084130No2006-08-012021-11-29US flag

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)Decomposes at 75MSDS
water solubility121 g/LMSDS
Predicted Properties
PropertyValueSource
logP-1Chemaxon
pKa (Strongest Acidic)1.8Chemaxon
Physiological Charge-2Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area80.59 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity13.53 m3·mol-1Chemaxon
Polarizability5.53 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-014i-2900000000-bb8469bf6f114d34339a
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-123.7583
predicted
DeepCCS 1.0 (2019)
[M+H]+127.08549
predicted
DeepCCS 1.0 (2019)
[M+Na]+135.86348
predicted
DeepCCS 1.0 (2019)

Transporters

Kind
Protein
Organism
Humans
Pharmacological action
No
Actions
Substrate
General Function
Not Available
Specific Function
Not Available
Gene Name
SLC20A1
Uniprot ID
Q8WUM9
Uniprot Name
Sodium-dependent phosphate transporter 1
Molecular Weight
73699.01 Da
References
  1. Biber J, Hernando N, Forster I: Phosphate transporters and their function. Annu Rev Physiol. 2013;75:535-50. doi: 10.1146/annurev-physiol-030212-183748. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
No
Actions
Substrate
General Function
Virus receptor activity
Specific Function
Sodium-phosphate symporter which seems to play a fundamental housekeeping role in phosphate transport by absorbing phosphate from interstitial fluid for normal cellular functions such as cellular m...
Gene Name
SLC20A2
Uniprot ID
Q08357
Uniprot Name
Sodium-dependent phosphate transporter 2
Molecular Weight
70391.755 Da
References
  1. Biber J, Hernando N, Forster I: Phosphate transporters and their function. Annu Rev Physiol. 2013;75:535-50. doi: 10.1146/annurev-physiol-030212-183748. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
No
Actions
Substrate
General Function
Sodium:phosphate symporter activity
Specific Function
Involved in actively transporting phosphate into cells via Na(+) cotransport in the renal brush border membrane. Probably mediates 70-80% of the apical influx.
Gene Name
SLC34A1
Uniprot ID
Q06495
Uniprot Name
Sodium-dependent phosphate transport protein 2A
Molecular Weight
68936.53 Da
References
  1. Biber J, Hernando N, Forster I: Phosphate transporters and their function. Annu Rev Physiol. 2013;75:535-50. doi: 10.1146/annurev-physiol-030212-183748. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
No
Actions
Substrate
General Function
Sodium:phosphate symporter activity
Specific Function
May be involved in actively transporting phosphate into cells via Na(+) cotransport. It may be the main phosphate transport protein in the intestinal brush border membrane. May have a role in the s...
Gene Name
SLC34A2
Uniprot ID
O95436
Uniprot Name
Sodium-dependent phosphate transport protein 2B
Molecular Weight
75758.535 Da
References
  1. Biber J, Hernando N, Forster I: Phosphate transporters and their function. Annu Rev Physiol. 2013;75:535-50. doi: 10.1146/annurev-physiol-030212-183748. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
No
Actions
Substrate
General Function
Sodium:phosphate symporter activity
Specific Function
May be involved in actively transporting phosphate into cells via Na(+) cotransport in the renal brush border membrane. Probably mediates 20-30% of the apical influx.
Gene Name
SLC34A3
Uniprot ID
Q8N130
Uniprot Name
Sodium-dependent phosphate transport protein 2C
Molecular Weight
63548.94 Da
References
  1. Kirchheiner J, Meineke I, Muller G, Roots I, Brockmoller J: Contributions of CYP2D6, CYP2C9 and CYP2C19 to the biotransformation of E- and Z-doxepin in healthy volunteers. Pharmacogenetics. 2002 Oct;12(7):571-80. [Article]

Drug created at November 30, 2015 19:10 / Updated at February 13, 2021 10:51